303 related articles for article (PubMed ID: 3487189)
1. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
[No Abstract] [Full Text] [Related]
2. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
[No Abstract] [Full Text] [Related]
3. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
Iakhontova OI; Dudanova OP; Khavinson VKh
Sov Med; 1990; (6):85-8. PubMed ID: 2396134
[No Abstract] [Full Text] [Related]
4. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
Balabolkin MI; Arion VIa; Petunina NA
Sov Med; 1987; (12):32-5. PubMed ID: 3502197
[No Abstract] [Full Text] [Related]
5. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
Sov Med; 1990; (6):111-3. PubMed ID: 2144365
[No Abstract] [Full Text] [Related]
6. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
[No Abstract] [Full Text] [Related]
7. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA
Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765
[TBL] [Abstract][Full Text] [Related]
8. [Effect of thymus cytomedins (thymalin) on the course of skin diseases].
Shaposhnikov OK; Gorbunov VF; Shchedrin VI; Karachunova TN; Vorob'ev VM
Vestn Dermatol Venerol; 1987; (4):4-7. PubMed ID: 3604444
[No Abstract] [Full Text] [Related]
9. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
[No Abstract] [Full Text] [Related]
10. [Clinico-immunologic evaluation of thymotropin efficacy in dermatosis patients].
Khamidov ShA; Keremet VV
Vestn Dermatol Venerol; 1988; (10):7-10. PubMed ID: 3223060
[No Abstract] [Full Text] [Related]
11. [The role of neutrophils in the pathogenesis of psoriasis and the effect of T-activin on them].
Korotkiĭ NG; Udzhukhu VIu; Vasil'eva LL; Redchenko EB; Bagandov TI
Vestn Dermatol Venerol; 1987; (7):19-22. PubMed ID: 3673241
[No Abstract] [Full Text] [Related]
12. [In vitro system for determining the use of immunocorrective agents in patients with disseminated psoriasis].
Vasil'eva LL; Amirova IA
Vestn Dermatol Venerol; 1984 Oct; (10):6-8. PubMed ID: 6334943
[No Abstract] [Full Text] [Related]
13. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
Ivanova LA
Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
[TBL] [Abstract][Full Text] [Related]
15. [Use of thymus gland peptides in chronic cholecystitis].
Rodoman GV; Belousov IuB; Kostrova MV; Petrov OA
Sov Med; 1991; (3):73-4. PubMed ID: 1882302
[No Abstract] [Full Text] [Related]
16. [Principles of immunocorrective therapy using the thymus preparation T-activin].
Arion VIa; Ivanushkin EF
Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
[No Abstract] [Full Text] [Related]
17. [Effectiveness of the new Soviet immunomodulator mielopid in the combined treatment of patients with chronic pyoderma].
Petrova IV; Leshchenko GM; Bystritskaia TF
Vestn Dermatol Venerol; 1989; (5):67-9. PubMed ID: 2773587
[TBL] [Abstract][Full Text] [Related]
18. [The immunocorrective therapy of pyoderma caused by staphylococci multiply resistant to antibiotics].
Rodionov AN; Khavinson VKh; Barbinov VV
Vestn Dermatol Venerol; 1990; (1):42-5. PubMed ID: 2327170
[TBL] [Abstract][Full Text] [Related]
19. [Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
Zapadniuk BV; Kravets AS; Iarosh AA; Shurinok LA
Vrach Delo; 1988 Aug; (8):84-6. PubMed ID: 3206892
[No Abstract] [Full Text] [Related]
20. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].
Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
Probl Tuberk; 1991; (12):52-4. PubMed ID: 1803376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
